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SUMMARY
There is a pressing need to develop novel anti-schistosomal drugs, as current treatment relies largely on praziquantel
(PZQ). To further strengthen current evidence of the anti-schistosomal properties of meﬂoquine (MQ), we studied the
temporal eﬀect of this compound in vitro and in vivo, and examined alterations on the tegumental surface of schistosomula
and adults of S. mansoni by means of scanning electron microscopy (SEM). Schistosomula and adults were each incubated
in vitro using MQ over a wide concentration range (1–100 mg/ml). In addition, mice infected with adult S. mansoni were
treated with a single oral dose of 400 mg/kg MQ, and worms were recovered 24, 48, 72, 96 and 120 h following treatment.
MQ showed a rapid onset of action on schistosomula in vitro ; 100 and 75 mg/ml of MQ killed schistosomula immediately;
the minimal lethal and eﬀective concentrations of MQ on schistosomula after 1 h were 25 and 5 mg/ml, respectively. Adult
worms incubated with 100 and 10 mg/ml of MQ were dead after 1 h and 24 h of incubation, respectively. A hepatic shift of
adult schistosomes was observed in mice already 24 h after treatment, and 120 h following treatment>98% of all worms
had translocated to the liver. SEM observations revealed extensive tegumental destruction, including blebbing, shrinking
and sloughing, particularly following in vitro incubation and on the tegument of female worms.
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INTRODUCTION
Schistosomiasis is a neglected tropical disease (NTD)
caused by blood ﬂukes of the genus Schistosoma.
Schistosoma haematobium, S. japonicum and
S.mansoni are the 3main species parasitizing humans
(Utzinger and Keiser, 2004; Gryseels et al. 2006).
It has been estimated that there are more than 207
million people infected worldwide, with 779 million
people at risk of infection (Steinmann et al. 2006).
The annual mortality rate in sub-Saharan Africa is
estimated to be as high as 280 000 (van derWerf et al.
2003). Estimates of the global burden of schisto-
somiasis range from 1.7 to 4.5 million disability-
adjusted life years (DALYs) (WHO, 2002, 2004) ;
the latter ﬁgure is likely to underestimate the true
burden, as it does not consider chronic disability
(Hotez et al. 2006). Revised estimates for schisto-
somiasis are at 3–70 million DALYs (King and
Dangerﬁeld-Cha, 2008).
Despite schistosomiasis being one of the most
prevalent and debilitating NTDs, a devoted drug
discovery and development programme does not
exist (Ridley and Kita, 2007). Since the late 1970s,
the treatment and control of schistosomiasis relies on
a single drug, namely praziquantel (PZQ) (Go¨nnert
and Andrews, 1977; Cioli and Pica-Mattoccia, 2003;
Utzinger and Keiser, 2004; Doenhoﬀ et al. 2008).
However, the heavy reliance and application of PZQ
within the frame of large-scale preventive chemo-
therapy treatment programmes might select for
drug-resistant parasites (Botros and Bennett, 2007;
Caﬀrey, 2007). In addition, PZQ has only moderate
activity against juvenile worms, which is an import-
ant deﬁciency in its spectrum of activity, as it re-
quires administration of a second PZQ dose after a
short interval to eliminate the parasites that have
since matured (Doenhoﬀ et al. 2008).
Nonetheless, in spite of the lack of dedicated
product development partnerships for helminth
diseases, a number of compounds with interesting
anti-schistosomal properties have been identiﬁed
by various research groups in recent years; for
example, peroxidic compounds (the semi-synthetic
artemisinins and the synthetic trioxolanes (OZs)),
4-phenyl-1,2,5-oxadiazole-3-carbonitrile-2-oxide and
the cysteine protease inhibitor K11777 (Abdulla
et al. 2007;Keiser andUtzinger, 2007;Utzinger et al.
2007;Xiao et al. 2007; Sayed et al. 2008;Caﬀrey et al.
2009). An important ﬁnding was that meﬂoquine
(MQ), an arylamino alcohol (4-quinoline-methanol),
developed by the Walter Reed Institute of Research
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in the early 1970s (Sweeney, 1981) and nowmarketed
for the prophylaxis and treatment of malaria, showed
promising anti-schistosomal activity in mice. Single
oral doses of 200–400 mg/kg to mice infected with
either juvenile or adult stages of S. mansoni or
S. japonicum resulted in high total or even complete
reductions in female worm burdens (Keiser et al.
2009). Treatment with a lower dose of 150 mg/kg
MQ revealed a signiﬁcantly reduced egg production
in S. mansoni-infected mice (Van Nassauw et al.
2008).
The aim of the present study was to further
strengthen the current evidence base of the anti-
schistosomal properties of MQ and to gain a ﬁrst
insight into the potential mode of action of the
drug. The dose-response relationships were studied
in vitro. The temporal drug eﬀect was monitored
in vitro and in vivo. In addition, alterations in the
tegumental surface of schistosomula and adult ﬂukes
were studied by means of scanning electron micro-
scopy (SEM).
MATERIALS AND METHODS
Experimental animals and parasites
All experiments were carried out at the Swiss
Tropical Institute (Basel, Switzerland), in accord-
ance with Swiss national animal welfare regulations.
Female NMRI mice (n=40, age=3 weeks, weight=
25 g) were purchased from Harlan (Horst, The
Netherlands).
Cercariae of S. mansoni (Liberian strain) were
obtained from infected intermediate host snails
(Biomphalaria glabrata) maintained according to
standard procedures (Keiser et al. 2009).
Drugs
Meﬂoquine ((RS)-(¡)-a-(2-Piperidinyl)-2,8-bis(tri-
ﬂuormethyl)-4-quinolinemethanol hydrochloride,MW=
414.81 g/mol) (MQ) was kindly provided by Mepha
AG (Aesch, Switzerland). For in vitro studies,
stock solutions of MQ (10 mg/ml) were prepared
in dimethyl sulfoxide (DMSO) (Fluka, Buchs,
Switzerland). For in vivo studies,MQ (40 mg/ml free
base) was suspended in 7% (v/v) Tween 80 and 3%
ethanol shortly before oral administration to mice.
In vitro studies on schistosomula
Cercariae of S. mansoni were mechanically trans-
formed into schistosomula (Ramalho-Pinto et al.
1974). Brieﬂy, 50 ml of an ice-cold cercarial sus-
pension were centrifuged and the packed volume of
cercariae was re-suspended in 2 ml of Minimal
Essential Medium (MEM) (Eagle, 1959) and vor-
texed for 2 min to trigger tail loss. For the isolation of
cercarial bodies, cold Hank’s Basal Salt Solution
(HBSS) was added to the cercarial suspension up to a
volume of 7 ml. After cooling on ice for 15 min,
the tail-rich supernatant was decanted and the
sedimented bodies were re-suspended in 7 ml of cold
HBSS. This procedure was repeated twice. The
schistosomula suspension was kept in Basch culture
medium (Basch, 1981) in an incubator at 37 xC in
an atmosphere of air, (95%)+CO2 (5%) for 1–3 h
until use.
To study the temporal drug eﬀect and the
concentration-response relationships, schistosomula
were incubated in 24-well plates (Costar), with
500–1000 schistosomula per well, in the presence of
diﬀerent concentrations of MQ. Each well contained
1 ml of Basch medium supplemented with 5% heat-
inactivated foetal calf serum (iFCS) and 100 U/ml
penicillin and 100 mg/ml streptomycin (Invitrogen,
Carlsbad, USA) and MQ at 100, 75, 50, 25, 15, 10, 5
or 1 mg/ml, respectively. Schistosomula incubated
with 1% DMSO, the highest concentration of drug
solvent, served as controls. The parasites were kept
in an incubator at 37 xC in an atmosphere of air,
(95%)+CO2 (5%) for up to 96 h.
Immediately after adding (0.125), 0.5, 1, 6, 17,
24, 48, 72 and 96 h after incubation with MQ, all
schistosomula were observed under a dissecting
microscope and the eﬀect of MQ was assessed, with
an emphasis on changes in worm motor activity,
morphological/tegumental alterations and the occur-
rence of death. These phenotypic changes were
scored using a viability scale of 0–3: (3=totally vital,
normally active, no morphological changes, 2=
slowed activity, ﬁrst morphological changes and
granularity visible, 1=minimal activity, severe mor-
phological changes and granularity, 0=all worms
dead, severe granularity) based on standard pro-
cedures for compound screening at WHO-TDR
(Ramirez et al. 2007) and the UCSF Sandler Center
(Caﬀrey et al. 2009). The minimal lethal concen-
tration (MLC), which is the minimum concentration
needed to kill all schistosomula and the minimal ef-
fective concentration (MEC), which is the minimum
concentration needed to observe any change in
viability or morphology of schistosomula were de-
termined after 1 h. All experiments were carried out
in duplicate and were repeated at least 3 times.
For SEM studies, samples of schistosomula in-
cubated with 3 diﬀerent concentrations of MQ (100,
10 and 1 mg/ml) were taken at diﬀerent time-points
(after 0.5, 1, 6, 24, 72 and 96 h). Specimens were
ﬁxed with 2.5% (v/v) glutaraldehyde in a phosphate-
buﬀered saline (PBS) (pH 7.4) for 24 h at 22–24 xC
(room temperature). After rinsing 3 times with PBS,
the specimens were stored in the same buﬀer at 4 xC
until use. Before SEM examination, the ﬂukes were
washed twice with double-distilled water, dehy-
drated in ascending ethanol concentrations and then
air-dried. Schistosomula were placed on aluminium
stubs, sputter coated with 20 nm gold particles and
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observed in a high-resolution SEM (Phillips XL30
ESEM) at an accelerating voltage of 5 kV.
In vitro studies of adult schistosomes
NMRImice were infected subcutaneously withy80
cercariae ofS.mansoni and euthanizedwith CO2 after
56 days. All adult schistosomes were collected from
the hepatic portal system and mesenteric veins and
removed from the liver by perfusion with ice-cold
PBS supplemented with heparin (Yolles et al. 1947;
Smithers and Terry, 1965). Schistosomes were in-
cubated in 24-well plates (Costar), placing 2male and
2 female worms in each well. Individual wells con-
tained RPMI 1640 culture medium (Invitrogen,
Carlsbad, USA) supplemented with 5% heat-
inactivated calf serum, 100 U/ml penicillin and
100 mg/ml streptomycin (Invitrogen, Carlsbad,USA).
Schistosomes were incubated in the presence of 100,
10 and 1 mg/ml MQ at 37 xC in an atmosphere of air
(95%)+CO2 (5%). Medium without and medium
with 1% DMSO (the highest concentration of drug
solvent used) served as controls. Before incubation
with MQ and immediately after incubation (0.125),
1, 6, 24, 48 and 72 h with MQ, all S. mansoni were
observed under a dissecting microscope. The eﬀect
of the drug was assessed with an emphasis on changes
in worm motor activity, morphological/tegumental
changes and death of worms. Death was deﬁned as no
movement observed for at least 2 min of examination
and no movement at the other observation time-
points. All experiments were carried out in duplicate
and were repeated at least 3 times. For SEM exam-
ination, thewormswere prepared as described above,
with the exception that the worms were critical-point
dried (Bomar SPC-900; Tacoma USA).
In vivo studies
NMRImice were infected as described above. At 7–8
weeks after infection, mice were treated with a single
oral dose of 400 mg/kg MQ, the most eﬀective dose
as established in our previous work (Keiser et al.
2009). At each time-point after treatment (24, 48,
72, 96 and 120 h), 3–6 mice were killed by cervical
dislocation and the mesentery and the liver were
collected. Schistosomes were removed from the
mesenteric veins, sexed and counted using a bino-
cular microscope. The liver was ﬂattened and ex-
amined for the presence of worms. The distribution
of schistosomes in the liver and mesenteric veins was
recorded. Schistosomes recovered from the mesen-
teric veins were further examined, and changes in
worm motor activity, morphological/tegumental
changes and death were documented. Worms were
then prepared for SEM examination.
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Fig. 1. Eﬀect of diﬀerent concentrations of MQ on the viability of Schistosoma mansoni schistosomula. Mean values of
viability using a viability score. Numbers derived from a minimum of 6 experiments (500–1000 schistosomula per
experiment were scored at each concentration). Open squares: 100 mg/ml; ﬁlled diamonds: 75 mg/ml; open diamonds:
50 mg/ml; ﬁlled triangles: 25 mg/ml; open circles: 15 mg/ml; ﬁlled circles: 10 mg/ml; ﬁlled squares: 5 mg/ml; open
triangles: 1 mg/ml; dashed and dotted line: Control (Basch medium); dashed line: Control (Basch medium+1%
DMSO).
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AP
Fig. 2. SEM observations of Schistosoma mansoni schistosomula after in vitro incubation. (A) Control, showing the
ventral sucker (VS) (=acetabulum), the anterior end (A) and the posterior end (P). (B) Control. Posterior region with
clearly deﬁned tegumental spines (S). (C) Thirty min after incubation with MQ (100 mg/ml). Shortened spines (S) and
blebbing (b) near the ventral sucker (VS) visible. (D) Thirty min after incubation with MQ (10 mg/ml). Contraction and
formation of wrinkles (W) visible. (E) Six h after incubation with MQ (10 mg/ml). A shrunken body with swelling (sw)
and many furrows (f) observed. (F) Six h after incubation with MQ (10 mg/ml). The tegument shows deep furrows (f)
and ﬂattened spines (fs). (G) Twenty-four h after incubation with of MQ (1 mg/ml). Shrunken (sh) tegument and
bending of the body. (H) Seventy-two h after incubation with MQ (1 mg/ml). A shrunken (sh) tegument visible.
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RESULTS
In vitro studies of schistosomula – dissecting
microscopic and SEM evaluations
The eﬀect of incubation with diﬀerent concentra-
tions of MQ on the viability of schistosomula for up
to 96 h is depicted in Fig. 1. In the absence of the
drug, schistosomula showed normal viability without
any morphological change for up to 24 h. Slight
morphological changes such as granularity, a shorter
body length with a falcate shape and reduced activity,
were observed after 48 h of incubation. Schisto-
somula were viable for at least 96 h.
Following incubation with the 2 highest con-
centrations of MQ (100 and 75 mg/ml) schistosomula
died rapidly; no movement was observed 3–4 min
after incubation. At this time-point, schistosomula
incubated with 1–10 mg/ml of MQ showed normal
movements, while schistosomula incubated with
15–50 mg/ml of MQ showed slowed activity (Fig. 1).
At 1 h after incubation with 25 and 50 mg/ml of
MQ all worms had died. Schistosomula incubated
with 5, 10 and 15 mg/ml showed only minimal ac-
tivity, including convulsions and contractions. Severe
morphological changes, such as dark granular and
crescent-shaped bodies associated with a reduction
in body lengths were seen. No eﬀect was observed
at the lowest concentration of MQ (1 mg/ml) at the
1 h time-point. Hence, the MLC and MEC of MQ
on schistosomula determined after 1 h were 25 and
5 mg/ml, respectively. In the presence of 1 mg/ml
of MQ schistosomula revealed ﬁrst morphological
changes and a decreased motility 48 h post-incu-
bation and 96 h after incubation most of the schisto-
somula were dead.
The structure and appearance of S. mansoni
schistosomula, incubated for 1 h in the absence of
MQ were similar to those described in the literature
(Crabtree andWilson, 1980; Basch and Basch, 1982).
In brief, schistosomula had a round shape, clearly
deﬁned head and tail regions and an incompletely
developed ventral (acetubulum) and oral sucker
(Fig. 2A). The tegument was covered by tegumental
spines, which were directed towards the posterior
end (Fig. 2B).
Thirty min after incubation with 10 and 100 mg/ml
of MQ, all schistosomula examined showed a change
in shape and extensive tegumental alterations.
Worms incubated with 100 mg/ml of MQ showed
intensive blebbing and shortened spines on the entire
tegumental surface (Fig. 2C). The incubation of
schistosomula with 10 mg/ml of MQ showed con-
traction and bending of the worm body, resulting in
the formation of wrinkles and a reduction of body
length byy50%. In addition, spines were shortened
(Fig. 2D). Schistosomula exposed to 1 mg/ml of MQ
showed no morphological changes 30 min after
incubation, and their structure and appearance was
similar to the controls.
At 6 h after incubation with 10 mg/ml MQ the
tegument of schistosomula showed many deep fur-
rows, swelling andﬂattened spines (Fig. 2E andF). At
this same time-point, the lowest concentration ofMQ
induced no tegumental alterations on schistosomula.
2
3
100 µg/ml
10 µg/ml
0
1
0 0.125 1 24 48 72
Vi
ab
ilit
y 
(ad
ult
 sc
his
tos
om
es
)
Time (h)
1 µg/ml
Control:RPMI 1640
Control:RPMI 1640 + 1%DMSO
Fig. 3. Eﬀect of diﬀerent concentrations of MQ on the viability of adult worms of Schistosoma mansoni. Mean values of
viability using a viability score. Numbers derived from a minimum of 6 experiments (in total 24 worms were scored at
each concentration). Open squares: 100 mg/ml; ﬁlled circles: 10 mg/ml; open triangles: 1 mg/ml; dashed and dotted line:
Control (RPMI 1640); dashed line: Control (RPMI 1640+1% DMSO).
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Slight tegumental alterations were observed on
worms incubated with 1 mg/ml of MQ after 72 h;
schistosomula were bending backwards (Fig. 2G)
and showed a shrunken tegument (Fig. 2G and H).
In vitro studies of adult S. mansoni – dissecting
microscopic and SEM evaluations
The dose-response relationships of MQ on adult
schistosomes for up to 72 h are given in Fig. 3.
Control female and male schistosomes showed
normal viability for up to 72 h. Egg production
was observed starting 24 h post-incubation. After
3–4 min of incubation with 100 mg/ml of MQ,
schistosomes displayed only minimal activities, in-
cluding slow convulsions and contractions. At 1 h
after incubation, adult worms exposed to this con-
centration were dead (Fig. 3).Worms incubated with
10 and 1 mg/ml of MQ showed normal activity at
the 1 h time-point. After 24 h, all schistosomes in-
cubated with 10 mg/ml of MQ were dead. In the
presence of 1 mg/ml of MQ, there was a reduction in
Fig. 4. SEM observations of untreated controls of adult Schistosoma mansoni recovered from a mouse 49 days post-
infection by portal perfusion. (A) Tail region of male worm, showing tubercles (T). (B) Higher magniﬁcation of (A):
tegument with tubercles (T), spines (S) and parallel-arranged wrinkles (W). (C) Head region of a male worm, showing
the ventral (VS) and the oral sucker (OS). (D) Higher magniﬁcation of (C): tegument of the head region with spines (S)
visible. (E) Female tegument of the mid-body region with parallel arranged ﬁssures (ﬁ). (F) Higher magniﬁcation of
(E). Spines (S) and pores (P) visible.
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the viability of female worms after 72 h compared
with untreated schistosomes. MQ suppressed egg
production in female worms incubated with all 3
concentrations used.
The tegumental surface of adult S. mansoni has
been described in a number of SEM studies (Miller
et al. 1972; Hockley, 1973; Hockley and McLaren,
1973). Brieﬂy, the surface of female schistosomes
is simpler and more uniform when compared with
the male worm (Basch and Basch, 1982; Gupta and
Basch, 1988). The latter sex showed many tubercles
on the dorsal body surface of the tail region (Fig. 4A).
At a higher magniﬁcation, spines on the top of
the tubercles and parallel-arranged wrinkles on the
tegument were visible (Fig. 4B). The head region of
both sexes of S. mansoni is characterized by an oral
and a ventral sucker (Fig. 4C) and a smooth tegument
with numerous tegumental spines (Fig. 4D). The
mid-body region of female adults had parallel
arranged ﬁssures (Fig. 4E) and, at a higher magni-
ﬁcation, tegumental spines and pores were visible
(Fig. 4F).
By 30 min after incubation with 100 mg/ml of
MQ extensive destruction was apparent on the
entire tegument of all adult schistosomes examined.
For example, on the mid-body region of female
worms, extensive sloughing was visible, leaving the
basal membrane exposed. In addition, the tegument
showed a roughened appearance and started to dis-
integrate (Fig. 5A). Figure 5B depicts a roughened
surface of amale specimen; at a highermagniﬁcation,
disintegration of the tegument, resulting in a ﬁbrous
Fig. 5. (Cont.)
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appearance, loss of tubercles, spines and the parallel-
arranged wrinkles, was visible (Fig. 5C). The whole
tegumental layer was destroyed.
After 1 h of incubation with 10 mg/ml of MQ,
tegumental alterations were observed on the oral
suckers of male worms and on the anterior and mid-
body regions of both males and females. For ex-
ample, blebbing and sloughing were observed on the
head region of amale worm. Even the inner surface of
the oral sucker of this worm was aﬀected (Fig. 5D).
Higher magniﬁcation revealed a disintegration of the
interspinal tegument of the oral sucker, resulting in
a roughened and ﬁbrous appearance, with a loss of
regularly arranged spines (Fig. 5E). A roughening
of the tegument was also observed on the ventral
suckers of male worms (not shown).While part of the
female mid-body regions showed no damage, other
mid-body regions revealed heavy sloughing, leaving
the underlying membrane exposed.
After incubation for 24 h with 10 mg/ml of MQ,
massive shrinking and swelling of the tegument was
observed on all female worms examined (Fig. 5F). At
a higher magniﬁcation of the ventral mid-body re-
gion, numerous blebs and swelling of the tegument,
associated with a loss of spines, ﬁssures and pores
were seen (Fig. 5G). Similar observations were made
when the tegument of the male ﬂukes was examined.
The male tegument was swollen and showed some
blebs (Fig. 5H).
By 48 h after incubation with 10 mg/ml of MQ,
sloughing aﬀected the whole bodies of male and fe-
male worms. The ventral suckers were also aﬀected
Fig. 5. (Cont.)
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(Fig. 5I). In many parts, the tegument lifted away
and left the basal membrane exposed. In addition,
tubercles had lost their spines (Fig. 5J). Additionally,
many blebs of diﬀerent sizes were visible on the basal
membrane. At the same time-point, worms incu-
bated with the lowest concentration ofMQ (1 mg/ml)
also revealed tegumental alterations with a more
severe tegumental response observed on female
worms. The female body was shrunken and formed
many wrinkles and deep furrows. In addition, the
tegument was swollen in some parts and blebbing
was observed (Fig. 5K and L). On the other hand,
the teguments of male worms were only slightly
roughened.
In vivo studies of adult S. mansoni – hepatic
translocation
The distribution of adult worms in the mesenteric
veins and the liver of S. mansoni infected mice 24, 48,
72, 96 and 120 h post-treatment with MQ (400 mg/
kg) is summarized in Table 1. A hepatic shift was
already observed 24 h post-treatment withMQ, with
61.8% of S. mansoni harboured in the liver. At 72 h
and 120 h post-treatment >92% and >98%, re-
spectively, of all worms had shifted to the liver.
In vivo studies of adult S. mansoni – dissecting
microscope and SEM evaluations
All adult ﬂukes recovered from the mesenteric veins
of mice at 24, 48, 72, 96 and 120 h after MQ treat-
ment were alive and viable.Wormswhich had shifted
to the liver could not be examined.
Twenty-four h after S. mansoni-infected mice
had received a single oral dose of MQ (400 mg/kg)
localized blebbing on the tegument was the main
response to drug action observed on worms re-
covered from the mesenteric veins (Fig. 6A). By
48 h post-treatment, blebbing increased, aﬀecting
the entire tegumental surface of the worms (Fig. 6B).
At 72 h after treatment, tegumental damage was
more severe and several worms, in particular the fe-
males, were now aﬀected. For example, the mid-body
tegument of a female S. mansoni became shrunken
(Fig. 6C). Again, many blebs were visible on the
teguments as depicted in Fig. 6D. The oral sucker of
a male specimen had a shrunken appearance result-
ing in formation of deep furrows. Moreover, some
parts of the oral sucker around the pharyngeal
opening were swollen. Small spines, which cover the
inner surface and the outer margin of the oral sucker
were not aﬀected (Fig. 6E).
Fig. 5. SEM observations of adult Schistosoma mansoni
after in vitro incubation with MQ. (A) Thirty min after
incubation with MQ (100 mg/ml). Tegument of the
mid-body region of a female worm. Extensive sloughing
(sl) exposing to view the basal membrane (bm).
Tegument shows roughening and disintegration (di).
(B) Thirty min after incubation with MQ (100 mg/ml).
Lateral and dorsal tegument around the gynecophoral
canal of a male worm depicting a roughened (r) surface.
(C) Higher magniﬁcation of (B). Tubercles (T) and
the lateral tegument disintegrate (di) resulting in
disappearance of the knobs, spines and the parallel-
arranged wrinkles. (D) One h after incubation with MQ
(10 mg/ml). Blebbing (b) and sloughing (sl) on the inner
surface of the oral sucker of a male specimen is visible.
(E) Higher magniﬁcation of (D) reveals disintegration
(di) of the tegument. Spines (S) are still apparent, but not
as clear and regular as in the control. (F) Twenty-four h
after incubation with MQ (10 mg/ml). The tegument of
the ventral mid-body region of a female worm is
shrunken (sh) and swollen (sw). (G) Higher magniﬁcation
of (F) shows many blebs (b) and swelling (sw) of the
tegument. (H) Twenty-four h after incubation with MQ
(10 mg/ml). Swollen (sw) male tegument of the ventral
mid-body region with many blebs (b) seen. (I) Forty-
eight h after incubation with MQ (10 mg/ml). Sloughing
(sl) on the anterior region and at the ventral sucker of a
male worm visible. (J) Forty-eight h after incubation
with MQ (10 mg/ml). Mid-body region of a male worm:
tegument with tubercles (T). The tegument shows
extensive sloughing (sl). In some parts it lifted
away leaving the basal membrane (bm) exposed.
(K) Forty-eight h after incubation with MQ (1 mg/ml).
Female with a shrunken (sh) and swollen (sw) mid-body
tegument. (L) At higher magniﬁcation of this body
region numerous blebs (b) were seen.
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At 96 h after treatment a slightly increased
tegumental response to drug treatment was obser-
ved on female worms when compared to previous
time-points. For example, the mid-body region of a
female worm examined showed a shrunken appear-
ance with deep furrows (Fig. 6F).
DISCUSSION
Recently, promising anti-schistosomal properties of
MQ against both adult and juvenile schistosomes
harboured by mice were found (Keiser et al. 2009)
and proof-of-concept trials have been launched with
MQ in S. mansoni or S. haematobium-infected chil-
dren in geographical regions in which malaria and
schistosomiasis are co-endemic. To further deepen
our understanding of the activity of this anti-malarial
drug against schistosomes, we investigated mor-
phological eﬀects and tegumental alterations of MQ
on S. mansoni juveniles (schistosomula) and adults in
vitro and in vivo. Dissecting microscopic investi-
gations demonstrated the temporal eﬀect of MQ on
viability and morphology as well as dose-response
relationships on schistosomula and adult S. mansoni.
In addition, SEM examinations revealed the pro-
gressive stages of damage to and disruption of the
tegumantal surface of the worm.
MQ had a very fast onset of action on schisto-
somula in vitro. In the presence of 100 and 75 mg/ml
worms died immediately. Concentrations ofo25 mg/
ml killed all schistosomula after 1 h of incubation.
Interestingly, a slightly slower onset of action was
observed when adult worms were incubated with
MQ in vitro. For example, while 10 mg/ml of MQ
killed schistosomula already after 6 h, the adults did
not die until 24 h of exposure in vitro. A much slower
onset of action was observed on adult worms col-
lected following in vivo treatment with MQ. Worms
collected from the mesenteric veins were still alive
up to 96 h following treatment, and only moderate
tegumental disruption, such as blebbing and a
shrunken body, was observed. However, severely
damaged worms might have already been expelled
and worms that had translocated to the liver could
not be examined. Hence, the evidence presented
might have underestimated the amount of damage
inﬂicted by the drug to the worm population as a
whole. Nonetheless, the discrepancy between the
eﬀect of the drug and the onset of action of MQ
in vitro and in vivo might be related to lower MQ
concentrations present in the livers and mesenteric
veins in mice compared with in vitro results.
Pharmacokinetic (PK) studies, measuring drug con-
centrations in the body and the target organs, might
aid elucidation of these diﬀerences observed in vitro
and in vivo. In addition, the eﬀect as well as onset of
action of MQ on diﬀerent stages of juvenile worms
(e.g. 21-day-old worms) in vitro and in vivo remains
to be elucidated.
Interestingly, worms incubated with MQ in vitro
died without the presence of haemin or red blood
cells. In contrast, no apparent eﬀect was observed
when schistosomes were incubated with the anti-
malarial artemether in vitro in the absence of haemin,
suggesting that artemether interacts with haemin to
exert a toxic eﬀect on the worms (Xiao et al. 2001).
Though the exact mechanism of action of MQ on
malaria parasites has not yet been entirely elucidated,
a disturbance of the haemoglobin metabolism due to
inhibition of the haematin polymerization and for-
mation of an insoluble polymer, termed haemozoin,
has been suggested (Dorn et al. 1998). A recent
morphological study ofS. japonicum in mice, showed
a pronounced dilatation of the gut of adult worms,
accompanied by focal or extensive peeling of gut
epithelial cells, or even focal collapse of the gut wall
(Zhang et al. 2009). Erythrocytes with accumulated
MQ entering the worm gut might inhibit haem
detoxiﬁcation, resulting in gut damage (Zhang et al.
2009). Hence, while an interference of MQ with the
haemoglobin digestion of schistosomes might play a
role in vivo, MQ seems to attack additional drug
targets in vitro. Further studies are necessary to
elucidate the multiple mechanisms of action of MQ,
which seems to be involved in the killing of schisto-
somes. It might also be useful to investigate whether
Table 1. Hepatic shift test following a single 400 mg/kg oral dose of MQ administered to mice infected
with Schistosoma mansoni
Time-point
of analysis
(h post-treatment)
No. of mice
investigated
No, of worms in
mesenteric veins No. of worms in liver
Total worm
burden
Mean (+/xS.D.*) % Mean (+/xS.D.) % Mean (+/xS.D.)
Control 6 42.6 (11.7) 97.3 1.2 (1.0) 2.7 43.8 (12.0)
24 4 14.3 (11.2) 37.9 23.3 (11.8) 61.8 37.7 (9.2)
48 4 29.5 (14.2) 56.3 25.5 (7.9) 46.3 55.0 (10.6)
72 4 5.7 (9.8) 7.6 69.0 (13.5) 92.4 74.7 (4.7)
96 4 3.0 (3.8) 6.3 44.8 (10.8) 93.7 47.8 (11.3)
120 3 0.5 (0.5) 1.1 44.0 (9.0) 98.9 44.5 (9.5)
* S.D., standard deviation.
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MQ acts synergistically with the host immune re-
sponse, similar to the chemotherapeutic eﬀect of
PZQ, which has been shown to be dependent on the
host antibody response (Brindley and Sher, 1987).
SEM is often used for documenting the eﬃcacy of
anti-schistosomal drugs. The 10–20 mm thick tegu-
ment (Neves et al. 2001) that covers the entire surface
of schistosomes represents an important drug target.
It consists of a double outer membrane (2 lipid
bilayers), has no glycocalyx (Hockley, 1973; Wilson
and Barnes, 1974; McLaren and Hockley, 1977), is
responsible for absorptive activities (Rogers et al.
1983) and is a protection barrier between the parasite
and the host (Hoﬀmann and Strand, 1996). In ad-
dition, it contains numerous ciliated or unciliated
bulb-shaped tubercles, which are sensory receptors
and associated with ring-shaped actin ﬁlaments
(Zhou and Podesta, 1992). Also, the spines of the
tubercles contain bundles of highly packed actin
ﬁlaments (Zhou and Podesta, 1992).
b
Fig. 6. SEM observations of adult Schistosoma mansoni recovered from mice treated with a single oral dose of MQ
(400 mg/kg). (A) Twenty-four h after treatment. Blebbing (b) on the dorsal mid-body tegument of a male worm is
visible. (B) Forty-eight h after treatment. Male dorsal tegument showing blebs (b). (C) Seventy-two h after treatment.
Tegument of the mid-body region of a female has a shrunken (sh) and swollen (sw) appearance. (D) Seventy-two h after
treatment. Dorsal mid-body male tegument reveals many blebs (b). (E) Seventy-two h after treatment. Oral sucker
(OS) of a male specimen shows a shrunken (sh) and swollen (sw) tegument. (F) Ninety-six h after treatment. The
shrunken (sh) mid-body region of a female S. mansoni with many furrows (f) is visible.
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We observed extensive tegumental damage on the
larvae and adult developmental stages of S. mansoni,
in particular following in vitro incubation, which
intensiﬁed progressively as the incubation period and
the concentration of MQ increased. Blebbing was
visible on the tegument of both treated juvenile and
adult ﬂukes. Blebbing is an indicator for stress and
has been observed in previous SEM studies evalu-
ating anti-schistosomal drugs (Jiraungkoorskul et al.
2005). Nonetheless, vesicle formation induced by
MQmight also occur due to the focal lysis of muscles
(Zhang et al. 2009). Interestingly, while in the
present study blebbing was observed on the tegu-
ment of both male and female adult S. mansoni,
vesiculation was absent from female S. japonicum
(Zhang et al. 2009). Flattened spines were observed
on the tegument of schistosomula and roughening,
sloughing and disintegration of the tegument were
other typical features observed on the tegument of
adult worms in the present investigation. In addition,
extensive swelling and furrowing were observed on
both development stages.
The eﬀect of PZQ on the tegument of S. mansoni
shows distinct diﬀerences, when compared to
MQ, though related tegumental alterations such as
sloughing, swelling, and loss or shortening of spines
have also been documented for PZQ (Xiao et al.
2000). First, in contrast to small- and also medium-
sized blebs observed in the present study a typical
feature seen on the tegument of S. mansoni treated
with PZQ was the presence of large-sized vesicles
protruding from the tegumental surface, most likely
due to swelling of the cytoplasm (Xiao et al. 1981).
Second, in the current study, the tegument of female
worms was slightly more aﬀected and females died
more rapidly when compared to male worms, in
particular following in vitro exposure to MQ, male
worms had a higher sensitivity to PZQ than female
worms in vitro (Pica-Mattoccia and Cioli, 2004)
and exhibited more extensive tegumental damage
than female worms following PZQ treatment (Shaw,
1990). The greater MQ susceptibility of females is
consistent with results from a previous in vivo study
(Keiser et al. 2009), in which greater reductions in
the female worm burden were observed compared
with total worm burden reductions. We speculated
that either a sex-speciﬁc interference of the drug with
the target might occur or that there are diﬀerent
targets for MQ in females compared with males
(Keiser et al. 2009). Alterations induced by arte-
mether on the tegument of S. mansoni have also been
well studied. Brieﬂy, severe tegumental damage was
observed on juvenile schistosomes, correlating with
the high eﬃcacy of artemether in killing 21-day-old
schistosomes (Xiao et al. 2000). Focal swelling and
fusion of tegumental ridges and occasionally slough-
ing was observed on adult S. mansoni recovered
from mice. Similar to the present results obtained
using MQ, female worms were more aﬀected
following treatment with artemether (Xiao et al.
2000).
We documented distinct morphological char-
acteristics of schistosomes incubated with MQ.
Schistosomula treated with MQ had a crescent-
shaped body and showed contraction resulting in a
reduction of the body length by approximately half.
In addition, a dark granular body was seen. Adult
worms showed convulsions after incubation with
MQ in vitro. In contrast, rapid spasmodic contrac-
tions of the worm body are the most prominent
morphological alterations induced by PZQ (Xiao
et al. 1984). Finally, in vivo studies showed that ex-
tensive structural changes to worms occurred within
15 min of treatment, and both female and male adult
worms died within 24 h following treatment with
PZQ (Shaw, 1983; Xiao et al. 1983). In contrast, in
our study worms were still alive several days post-
treatment of mice withMQ and nearly all worms had
shifted to the liver after 72 h. Interestingly, a more
rapid hepatic translocation was observed with MQ
on S. japonicum, all worms had moved to the liver
48 h after treatment (Zhang et al. 2009).
In conclusion, we demonstrated that MQ induces
extensive morphological and tegumental alterations
on both S. mansoni schistosomula and adults in vitro
and in vivo. Importantly, given the distinct mor-
phological and tegumental changes caused by MQ
compared with PZQ, the only other eﬀective anti-
schistosomal drug available, we speculate that both
drugs attack diﬀerent targets ; hence, it is suggested
that no cross-resistance will occur. Thus, the present
ﬁndings provide a sound basis for further in-depth
studies of the anti-schistosomal properties of MQ,
both in the laboratory and in the ﬁeld.
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